---
title: "Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rule"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295388490.md"
description: "Arcadia Biosciences received a Nasdaq notice on Aug. 4, 2026, for failing the $1 minimum bid price rule due to 30 consecutive trading sessions below this threshold. The company has until Feb. 1, 2027, to regain compliance by maintaining a closing bid price of at least $1 for 10 consecutive business days. Options under review include a reverse stock split; failure to cure may result in delisting."
datetime: "2026-08-10T10:05:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295388490.md)
  - [en](https://longbridge.com/en/news/295388490.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295388490.md)
generator: "portal-rs"
---

# Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rule

-   Arcadia Biosciences received a Nasdaq notice on Aug. 4, 2026 for failing the $1 minimum bid price rule. \* Noncompliance was triggered by 30 straight sessions below $1, from June 22, 2026 to Aug. 3, 2026. \* RKDA keeps trading on the Nasdaq Capital Market while it has until Feb. 1, 2027 to regain compliance. \* Compliance requires a closing bid price of at least $1 for 10 consecutive business days, subject to Nasdaq discretion. \* A reverse stock split is among options under review; failure to cure could lead to delisting risk. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-340664), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RKDA.US](https://longbridge.com/en/quote/RKDA.US.md)

## Related News & Research

- [VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase](https://longbridge.com/en/news/296932909.md)
- [Petrolia Noco announces availability of Q2 2026 report](https://longbridge.com/en/news/296871879.md)
- [Ameriprise Financial declares Q3 2026 dividend of R$ 1.48 per unit](https://longbridge.com/en/news/297021432.md)
- [Leggett & Platt declares Q3 2026 dividend of R$ 0.17 per unit](https://longbridge.com/en/news/297016902.md)
- [Halliburton declares Q3 2026 dividend of R$ 0.59 per unit](https://longbridge.com/en/news/296949616.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**